BARCLAYS PLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$158,000
+129.0%
132,775
+245.7%
0.00%
Q2 2022$69,000
-55.2%
38,408
-49.6%
0.00%
Q1 2022$154,000
-81.1%
76,274
-74.6%
0.00%
Q4 2021$814,000
+214.3%
299,892
+416.7%
0.00%
Q3 2021$259,000
+43.1%
58,039
+85.1%
0.00%
Q2 2021$181,000
-71.0%
31,358
-64.7%
0.00%
Q1 2021$624,000
-55.3%
88,935
-69.4%
0.00%
Q4 2020$1,395,000
-40.3%
290,741
-27.5%
0.00%
-100.0%
Q3 2020$2,336,000
-47.2%
400,902
-38.8%
0.00%
-66.7%
Q2 2020$4,421,000
+16.7%
655,206
+10.0%
0.00%0.0%
Q1 2020$3,788,000
-62.4%
595,512
-38.4%
0.00%
-50.0%
Q4 2019$10,082,000
+563.3%
967,048
+150.1%
0.01%
+500.0%
Q3 2019$1,520,000
-60.7%
386,733
+48.5%
0.00%
-50.0%
Q2 2019$3,872,000
-0.2%
260,436
+66.6%
0.00%
-33.3%
Q1 2019$3,879,000
+20.7%
156,324
-12.6%
0.00%0.0%
Q4 2018$3,214,000
-52.3%
178,918
-22.0%
0.00%
-40.0%
Q3 2018$6,733,000
-46.8%
229,276
-17.6%
0.01%
-54.5%
Q2 2018$12,645,000
+9.7%
278,116
+27.3%
0.01%
+22.2%
Q1 2018$11,530,000
-75.5%
218,390
-68.4%
0.01%
-76.9%
Q4 2017$47,043,000
+105.3%
691,824
+148.8%
0.04%
+62.5%
Q3 2017$22,915,000
-57.6%
278,102
-51.8%
0.02%
-59.3%
Q2 2017$54,066,000
+1201.5%
577,442
+785.4%
0.06%
+1080.0%
Q1 2017$4,154,000
-71.6%
65,221
-80.2%
0.01%
-68.8%
Q4 2016$14,613,000
+281.0%
328,967
+209.3%
0.02%
+220.0%
Q3 2016$3,835,000
+149.0%
106,373
-5.2%
0.01%
+150.0%
Q2 2016$1,540,000
-55.6%
112,178
-38.6%
0.00%
-60.0%
Q1 2016$3,469,000
+80.3%
182,586
+232.3%
0.01%
+150.0%
Q4 2015$1,924,000
-9.6%
54,949
+134.9%
0.00%
-33.3%
Q3 2015$2,128,000
-62.4%
23,388
-64.0%
0.00%
-50.0%
Q2 2015$5,657,000
+3883.8%
65,014
+3287.9%
0.01%
Q1 2015$142,000
+51.1%
1,919
+15.0%
0.00%
Q4 2014$94,000
-66.4%
1,668
-73.1%
0.00%
Q3 2014$280,000
-97.4%
6,194
-97.7%
0.00%
-100.0%
Q2 2014$10,921,000
+2343.2%
266,370
+3996.7%
0.01%
+1100.0%
Q1 2014$447,000
-30.7%
6,502
-39.6%
0.00%0.0%
Q4 2013$645,000
-25.9%
10,757
-25.9%
0.00%0.0%
Q3 2013$871,000
+580.5%
14,519
+658.6%
0.00%
Q2 2013$128,0001,9140.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders